Agomelatine
- Generic Name
- Agomelatine
- Brand Names
- Valdoxan
- Drug Type
- Small Molecule
- Chemical Formula
- C15H17NO2
- CAS Number
- 138112-76-2
- Unique Ingredient Identifier
- 137R1N49AD
- Background
Agomelatine is structurally closely related to melatonin. Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. Agomelatine was developed in Europe by Servier Laboratories Ltd. and submitted to the European Medicines Agency (EMA) in 2005. The Committee for Medical...
- Indication
Agomelatine is indicated to treat major depressive episodes in adults.
- Associated Conditions
- Major Depressive Episode
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath